Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Differences in Experiences Reported By Patients with Acute and Chronic Leukemia: A Global Survey

Zack Pemberton-Whiteley, Samantha Nier, Jan Geissler, Sophie Wintrich, Anne-Pierre Pickaert, Sam Salek, Esther Natalie Oliva, Tatiana I. Ionova, Jennie Bradley

Blood (2022) 140 (Supplement 1): 13273–13275.

https://doi.org/10.1182/blood-2022-163466

Published: 2022

Journal Articles

Experiences and Views of Leukemia Patients: A Global Survey

Zack Pemberton-Whiteley, Samantha Nier, Nick York, Deborah Baker, Michael Rynne, Nicole Schroeter, Denis Costello, Lidija Pecova, Esther Natalie Oliva, Tatiana I. Ionova, Sam Salek, Jennie Bradley

Blood (2022) 140 (Supplement 1): 5258–5259.

https://doi.org/10.1182/blood-2022-163309

Published: 2022

Journal Articles

Tumor Microenvironment in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma before and after Anti-PD-1 Therapy

Artem A. Gusak, Kirill V. Lepik, Natalia B. Mikhailova, MD PhD, Elena Kondakova, Yuri R. Zalaylov, Marina O. Popova, MD PhD, Tatiana I. Ionova, Prof., Aleksandr D. Kulagin, MD PhD, Boris V. Afanasyev, Vadim Baykov

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-138858

Published: 2020

Journal Articles

The Role of BCR-ABL Levels Fluctuations and Loss of Deep Molecular Response after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia in the Prospective Trial RU-SKI

Anna Petrova, MD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anastasiya Bykova, MD, Irina Nemchenko, MD PhD, Olga Pospelova, MD, Margarita Gurianova, MD, Nikolay Tsyba, MD PhD, Tatiana I. Ionova, Prof., Anna G. Turkina, Prof., MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-141798

Published: 2020

Journal Articles

Reduced Intensity Conditioning Regimens in Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis patients.

Andrei A. Novik, MD, FRCP, Alexey N. Kuznetsov, Vladimir Y Melnichenko, Denis A Fedorenko, Andrey Kartashov, Ruslana V Kruglina, Tatiana I Ionova, Kira Kurbatova, Gary J Gorodokin

Blood (2009) 114 (22): 2317.

https://doi.org/10.1182/blood.V114.22.2317.2317

Published: 2009

Journal Articles

Mini-Autologous Hematopoietic Stem Cell Transplantations as a New Treatment Modality for Multiple Sclerosis Patients

Andrei A Novik, Vladimir Y Melnichenko, Denis A Fedorenko, Ruslana V Kruglina, Tatiana I Ionova, Anton V Kishtovich, Roman I Ivanov, Gary J Gorodokin

Blood (2008) 112 (11): 4454.

https://doi.org/10.1182/blood.V112.11.4454.4454

Published: 2008

Journal Articles

Four Strategies of Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis Treatment

Andrei A. Novik, MD, FRCP, Boris V Afanasyev, Igor A Lisukov, Oleg A Rykavicin, Alexandr A Myasnikov, Tatiana I Ionova, Vladimir Y Melnichenko, Denis A Fedorenko, Nina E Osipova, Artur E Zdorov, Ruslana V Kruglina, Anton V Kishtovich, Roman I Ivanov, Gary J Gorodokin

Blood (2008) 112 (11): 4432.

https://doi.org/10.1182/blood.V112.11.4432.4432

Published: 2008

Journal Articles

Multicenter Experience of High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT) in Multiple Sclerosis (MS) Patients.

Blood (2006) 108 (11): 3072.

https://doi.org/10.1182/blood.V108.11.3072.3072

Published: 2006

Journal Articles

Quality of Life (QoL) Impairment and International Prognostic Index (IPI) in New Aggressive Non-Hodgkin’s Lymphoma (ANHL) Patients.

Andrei A. Novik, Tatiana I. Ionova, PhD, Anton V. Kishtovich, PhD, Alexander A. Myasnikov, Tatiana V. Chagorova, MD, PhD, Mikhail V. Kopp, Nina E. Osipova, MD, Julia K. Lebedeva, MD, Natalia N. Malakchova, MD, Anastasia V. Pankova, Denis A. Fedorenko, MD, PhD, Gary I. Gorodokin, MD

Blood (2005) 106 (11): 4651.

https://doi.org/10.1182/blood.V106.11.4651.4651

Published: 2005

Journal Articles

Treatment Outcomes in Multiple Sclerosis (MS) Patients after Early, Conventional and Salvage High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT).

Yury L. Shevchenko, Andrei A. Novik, Boris V. Afanasiev, Igor A. Lisukov, Tatiana I. Ionova, PhD, Andrei D. Kulagin, MD, Olga A. Malysheva, MD, Gennady N. Bisaga, MD, PhD, Vladimir J. Melnichenko, MD, PhD, Sergei V. Voloshin, MD, PhD, Denis A. Fedorenko, MD, PhD, Inna V. Vereschagina, MD, Anton V. Kishtovich, PhD, Yury N. Fedotov, MD, PhD, Gary I. Gorodokin, MD

Blood (2005) 106 (11): 5467.

https://doi.org/10.1182/blood.V106.11.5467.5467

Published: 2005

Journal Articles

Clinical and Quality of Life Outcomes in Patients with Multiple Sclerosis (MS) after High Dose Chemotherapy(HDCT)+Autologous Stem Cell Transplantation (ASCT).

Yury L. Shevchenko, Andri A. Novik, Boris V. Afanasiev, Igor A. Lisukov, Yury N. Fedotov, MD, Tatiana I. Ionova, PhD, Alexandr D. Kulagin, PhD, Olga A. Malysheva, MD, Gennadi N. Bisaga, PhD, Vladimir Y. Melnichenko, PhD, Lubov V. Chelombit, MD, Sergei V. Voloshin, PhD, Denis A. Fedorenko, PhD, Inna V. Vereschagina, MD, Anton V. Kishtovich, PhD

Blood (2004) 104 (11): 1875.

https://doi.org/10.1182/blood.V104.11.1875.1875

Published: 2004

Journal Articles

Heterogeneity of New Hodgkin’s Disease Patients in Terms of Their Quality of Life.

Andri A. Novik, Tatiana I. Ionova, PhD, Anton V. Kishtovich, PhD, Olga S. Uspenskaya, MD, Nina E. Osipova, MD, Denis A. Fedorenko, PhD

Blood (2004) 104 (11): 3125.

https://doi.org/10.1182/blood.V104.11.3125.3125

Published: 2004

NARROW

Differences in Experiences Reported By Patients with Acute and Chronic Leukemia: A Global Survey

Experiences and Views of Leukemia Patients: A Global Survey

Tumor Microenvironment in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma before and after Anti-PD-1 Therapy

The Role of BCR-ABL Levels Fluctuations and Loss of Deep Molecular Response after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia in the Prospective Trial RU-SKI

Reduced Intensity Conditioning Regimens in Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis patients.

Mini-Autologous Hematopoietic Stem Cell Transplantations as a New Treatment Modality for Multiple Sclerosis Patients

Four Strategies of Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis Treatment

Multicenter Experience of High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT) in Multiple Sclerosis (MS) Patients.

Quality of Life (QoL) Impairment and International Prognostic Index (IPI) in New Aggressive Non-Hodgkin’s Lymphoma (ANHL) Patients.

Treatment Outcomes in Multiple Sclerosis (MS) Patients after Early, Conventional and Salvage High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT).

Clinical and Quality of Life Outcomes in Patients with Multiple Sclerosis (MS) after High Dose Chemotherapy(HDCT)+Autologous Stem Cell Transplantation (ASCT).

Heterogeneity of New Hodgkin’s Disease Patients in Terms of Their Quality of Life.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only